JPH08157386A - Athlete's foot treating agent - Google Patents
Athlete's foot treating agentInfo
- Publication number
- JPH08157386A JPH08157386A JP6341171A JP34117194A JPH08157386A JP H08157386 A JPH08157386 A JP H08157386A JP 6341171 A JP6341171 A JP 6341171A JP 34117194 A JP34117194 A JP 34117194A JP H08157386 A JPH08157386 A JP H08157386A
- Authority
- JP
- Japan
- Prior art keywords
- athlete
- foot
- skin
- treating agent
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 title claims abstract description 15
- 201000004647 tinea pedis Diseases 0.000 title claims abstract description 15
- 239000000284 extract Substances 0.000 claims abstract description 8
- 235000004611 garlic Nutrition 0.000 claims abstract description 7
- 235000021419 vinegar Nutrition 0.000 claims abstract description 6
- 239000000052 vinegar Substances 0.000 claims abstract description 6
- 235000020971 citrus fruits Nutrition 0.000 claims abstract description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 3
- 241000287828 Gallus gallus Species 0.000 claims description 3
- 235000013601 eggs Nutrition 0.000 claims description 3
- 239000008267 milk Substances 0.000 claims description 3
- 235000013336 milk Nutrition 0.000 claims description 3
- 210000004080 milk Anatomy 0.000 claims description 3
- 241000207199 Citrus Species 0.000 claims description 2
- 244000245420 ail Species 0.000 claims 1
- 241000223238 Trichophyton Species 0.000 abstract description 7
- 240000002234 Allium sativum Species 0.000 abstract description 6
- 239000003795 chemical substances by application Substances 0.000 abstract description 4
- 239000004615 ingredient Substances 0.000 abstract description 4
- 240000000691 Houttuynia cordata Species 0.000 abstract description 3
- 235000013719 Houttuynia cordata Nutrition 0.000 abstract description 3
- 230000001954 sterilising effect Effects 0.000 abstract description 3
- 235000020247 cow milk Nutrition 0.000 abstract 1
- 239000002075 main ingredient Substances 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 13
- 239000003814 drug Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 8
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 230000007794 irritation Effects 0.000 description 5
- 230000037311 normal skin Effects 0.000 description 5
- 210000000434 stratum corneum Anatomy 0.000 description 5
- 229940124597 therapeutic agent Drugs 0.000 description 5
- 244000025254 Cannabis sativa Species 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 238000004299 exfoliation Methods 0.000 description 3
- XLYLQUQHYUOPIW-UHFFFAOYSA-N 3-oxo-Tetradecanal Chemical compound CCCCCCCCCCCC(=O)CC=O XLYLQUQHYUOPIW-UHFFFAOYSA-N 0.000 description 2
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- QBDCOUHKEVYWLO-UHFFFAOYSA-N Decanoylacetaldehyde Natural products CCCCCCCCCC(=O)CC=O QBDCOUHKEVYWLO-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 235000010081 allicin Nutrition 0.000 description 2
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 230000007306 turnover Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- -1 Upon grinding Chemical compound 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- XUHLIQGRKRUKPH-GCXOYZPQSA-N Alliin Natural products N[C@H](C[S@@](=O)CC=C)C(O)=O XUHLIQGRKRUKPH-GCXOYZPQSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 241000951471 Citrus junos Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 206010027627 Miliaria Diseases 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- XUHLIQGRKRUKPH-UHFFFAOYSA-N S-allyl-L-cysteine sulfoxide Natural products OC(=O)C(N)CS(=O)CC=C XUHLIQGRKRUKPH-UHFFFAOYSA-N 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- XUHLIQGRKRUKPH-DYEAUMGKSA-N alliin Chemical compound OC(=O)[C@@H](N)C[S@@](=O)CC=C XUHLIQGRKRUKPH-DYEAUMGKSA-N 0.000 description 1
- 235000015295 alliin Nutrition 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 230000002160 anti-trichophyton Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000008393 encapsulating agent Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、水虫治療剤に関するも
のである。TECHNICAL FIELD The present invention relates to a therapeutic agent for athlete's foot.
【0002】[0002]
【従来の技術】水虫は、白癬菌という糸状菌の感染によ
って発症するものであり、従来その治療にはヨードチン
キ、サリチル酸ワセリン等の抗白癬菌剤が使用されてい
た。BACKGROUND OF THE INVENTION Athlete's foot is caused by infection with a filamentous fungus called Trichophyton, and conventionally, anti-trichophyton agents such as tincture of iodine and vaseline salicylate have been used for its treatment.
【0003】[0003]
【発明が解決しようとする課題】ところで、この種の水
虫治療剤としては、実効があると共に、副作用や刺激性
のない安全性の高いものが望まれている。そこで、例え
ば特開昭49−20319号公報所載のミカンの抽出液
を主成分とするものや、特開昭57−134420号公
報所載のアロエの抽出液を主成分とするもののように植
物のエキスを主成分として副作用や刺激性を緩和させよ
うとするものが提示されている。そこで、本発明者は、
白癬菌の殺菌に有効な成分を含む植物(薬草、野草等)
について鋭意研究を重ね、さらに、食酢の殺菌作用と人
の角質層への浸透作用に着目し、本発明をするに至っ
た。すなわち、本発明もまた上記の実情に鑑み、植物の
抽出液を主成分とし、無害、安全で白癬菌の殺菌効果の
高い水虫治療剤を提供することを目的とするものであ
る。By the way, as a therapeutic agent for athlete's foot of this kind, a highly safe agent which is effective and has no side effects or irritation is desired. Therefore, plants such as those containing an extract of mandarin orange described in JP-A-49-20319 as a main component and those containing an extract of aloe described in JP-A-57-134420 as a main component It has been proposed that the main component of the extract is to reduce side effects and irritation. Therefore, the present inventor
Plants that contain ingredients that are effective in sterilizing Trichophyton (medicinal herbs, wild plants, etc.)
The present invention has been completed by paying attention to the bactericidal action of vinegar and the action of penetrating human stratum corneum. That is, in view of the above-mentioned circumstances, the present invention also aims to provide a therapeutic agent for athlete's foot that contains a plant extract as a main component, is harmless, is safe, and has a high bactericidal effect on Trichophyton.
【0004】[0004]
【課題を解決するための手段】このため本発明の水虫治
療剤は、食酢と、にんにく、ドクダミ草の抽出エキスと
を主成分としたことを特徴としている。その他の成分と
して、鶏卵、柑橘類の絞り汁、牛乳から選ばれた少なく
とも一つを含むことができる。For this reason, the therapeutic agent for athlete's foot of the present invention is characterized by containing vinegar, garlic, and extract of Dodami edible grass as main components. As other components, at least one selected from chicken eggs, citrus juice and milk can be included.
【0005】[0005]
【作用】本発明の水虫治療剤は、食酢が人の角質層へ浸
透する作用により、これに加えたにんにく、ドクダミ草
の抽出エキス中の白癬菌の殺菌に有効な成分が患部に浸
透し効果的に作用すると推定される。また、にんにくに
は、多量の粘質物が含まれているので、塗布後の薬剤の
揮発を抑制し患部への作用を持続させることができる。[Action] The athlete's foot remedy of the present invention has the effect that vinegar penetrates into the stratum corneum of humans, and the garlic and the ingredient effective in sterilizing Trichophyton in the extract of Dokudami grass penetrate into the affected area. It is presumed that it will work. Further, since a large amount of mucilage is contained in garlic, it is possible to suppress the volatilization of the drug after application and maintain the action on the affected area.
【0006】ところで、人の正常な皮膚の新陳代謝は、
表皮の基底層で絶えず新しい細胞が作られ、成熟しなが
ら表面へと移動する。そして、無核の細胞角質となり、
やがて角片となって剥がれ落ちる皮膚の自然活動、所謂
ターンオーバー活動が行われている。本剤は、正常な皮
膚のターンオーバー活動を阻害することなく、白癬菌に
冒された部分のみに反応し、疾患部分のみの角質角片の
剥離促進作用が認められた。By the way, the metabolism of normal human skin is
New cells are constantly created in the basal layer of the epidermis and migrate to the surface while maturing. And it becomes anucleated cell keratin,
The so-called turnover activity, which is a natural activity of the skin that eventually peels off into horn pieces, is carried out. This drug reacted only with the part affected by Trichophyton without inhibiting the normal skin turnover activity, and was observed to promote exfoliation of corneous horn fragments only in the diseased part.
【0007】にんにくの主成分は、アリインであるが、
擦り潰すことにより、酸素アリナーゼの活性によりアリ
シンを発生させる。このアリシンはかなりの低濃度に希
釈しても充分な抗菌力があることは周知のとおりであ
る。ドクダミ草の抽出エキスの主成分は、デカノイルア
セトアルデヒドである。このデカノイルアセトアルデヒ
ドもブドウ球菌や糸状菌に対して強力な抗菌作用がある
ことが判明している。また、ドクダミ草に含まれる葉緑
素(クロロフィル)が、患部の角質角片の剥離により失
なわれた皮膚の肉芽組織の回復を助けるものと推定され
る。The main component of garlic is alliin,
Upon grinding, allicin is generated by the activity of oxygen allinase. It is well known that this allicin has sufficient antibacterial activity even when diluted to a considerably low concentration. The main component of the extract of Dokudami grass is decanoylacetaldehyde. It has been found that this decanoylacetaldehyde also has a strong antibacterial action against staphylococci and filamentous fungi. It is also presumed that chlorophyll (chlorophyll) contained in Dokudomi-kusa helps recovery of the granulation tissue of the skin, which has been lost due to exfoliation of the horny horny piece of the affected area.
【0008】[0008]
【実施例】以下、本発明を実施例により具体的に説明す
る。食酢(酸度20%のもの)300mlを、下記の成分
と混合しミキサーで粉砕して得られた混合液を暗所で1
週間程貯蔵した後、濾過して繊維質のものを取り除き、
水虫治療剤を得た。 生にんにく 50g 生ドクダミ草 50g 柑橘類(ゆず・レモン) 50gEXAMPLES The present invention will be specifically described below with reference to examples. Mix 300 ml of vinegar (with 20% acidity) with the following ingredients and pulverize with a mixer to obtain a mixed solution 1 in the dark.
After storing for about a week, filter to remove fibrous material,
A remedy for athlete's foot was obtained. 50 g raw garlic 50 g raw dodami grass 50 g citrus fruits (yuzu / lemon) 50 g
【0009】次に本実施例に係る水虫治療剤の使用方法
及び使用結果を示す。本剤は患部への刺激感を考慮し蒸
留水にて酸度を5%〜18%程度に希釈して使用する
が、蒸留水に替えて牛乳で希釈してもよい。Next, a method of using the remedy for athlete's foot and a result of use will be shown. This agent is used by diluting it with distilled water to an acidity of about 5% to 18% in consideration of the feeling of irritation to the affected area, but it may be diluted with milk instead of distilled water.
【0010】6名の被験者を患部症状の程度により軽度
の者2名(乾性・湿性各1名)、中度の者2名(乾性・
湿性各1名)、重度の者2名(乾性・湿性各1名)の3
つのグループに区分して、それぞれ本剤を酸度18%に
希釈したものを朝・晩の2回ずつ患部に塗布して治験を
行った。以下、治癒状態の観察結果を示す。 (1).乾性疾患の者3名は、使用開始4日目頃から皮膚表
面の角質層の角片剥離現象が少しずつ確認できはじめ
た。その後、3名共に角片剥離現象が繰り返され、軽度
の者は約4週間、中・重度の者も45日経過した頃には
正常な皮膚が再生した。 (2).湿性疾患の軽度の者について1週間経過後観察する
と、患部の角質層が白くふやけて肥厚しており、17日
後には肥厚部分が剥離しかかっていたので、入浴後、そ
の部分を引っ張ると無理なく剥離した。その後、皮膚表
面の薄皮の剥離が繰り返され33日経過した頃には正常
な皮膚が再生した。 (3).湿性疾患の中度の者は指の股間の皮膚が裂けてお
り、刺激痛を訴えたので、2回目から酸度9%のものに
切り替えた、1週間経過後、患部を観察すると、裂けて
いた部分が塞がり薄皮が再生し、裂けていなかった部分
は白くふやけて肥厚していた。以後、刺激痛が無くなっ
たので酸度18%のものに再度切り替えた。すると、3
7日経過後には正常な皮膚が再生した。 (4).重度の者は、本剤を塗布した当初は、患部が糜爛し
た状態であったが、1週間経過後、患部を観察すると、
糜爛していた部分が流れ落ち薄皮に覆われ皮膚が赤味を
帯びていた。その後、皮膚表面の薄皮の剥離が繰り返さ
れ42日経過した頃には正常な皮膚が再生した。Six subjects were mild (2 dry and 1 wet each) and 2 moderate (dry
3 for wetness (1 person each) and 2 severe persons (1 each for dry and wetness)
The product was divided into two groups, and the product was diluted to 18% acidity and applied to the affected area twice a day in the morning and evening, and a clinical trial was conducted. The observation results of the healing state are shown below. (1). From the 4th day after the start of use, three people with dry disease were gradually able to confirm the exfoliation phenomenon of the stratum corneum on the skin surface. After that, the peeling phenomenon of the exfoliated pieces was repeated in all three persons, and the normal skin was regenerated for about 4 weeks for the mild person and after 45 days for the moderate and severe persons. (2). When a person with mild wetness was observed after 1 week, the stratum corneum of the affected area was white and swollen and thickened, and after 17 days, the thickened part was about to peel off, so after bathing, that part When peeled, it peeled off without difficulty. After that, the thin skin on the skin surface was repeatedly peeled off, and normal skin was regenerated after 33 days had passed. (3). A person with moderate wetness had a tear in the crotch of the fingers and complained of irritation pain. So, after switching from the second time to one with an acidity of 9%, after 1 week, the affected area was observed. , The part that had been torn was closed and the skin was regenerated, and the part that had not been torn was white and thickened and thickened. After that, since the irritation pain disappeared, the acid level was switched to 18% again. Then 3
Normal skin regenerated after 7 days. (4) .In severe cases, the affected area was in an erosive state at the beginning of application of this drug, but one week later, when the affected area was observed,
The erosive part fell off and was covered with thin skin, and the skin was reddish. Thereafter, the thin skin on the skin surface was repeatedly peeled off, and normal skin was regenerated after 42 days had passed.
【0011】上述のように、本剤は水虫患部へ塗布した
後そのまま放置してもよいが、本剤を塗布した後に患部
から揮発するのを防止すると、角質層への本剤の浸透効
果及び殺菌効果が持続し、好ましい効果が得られること
が判明した。そのため、気密性の高いゴム等にて靴下、
手袋、指サック及び絆創膏状の被包体を作り、これらを
併用し、患部に本剤を塗布したカット綿を装着した後、
これらの被包体により密封あるいは密閉するようにする
と、さらに好ましい治癒効果があがる。また、本剤は、
酸性質の高い液剤で構成されているので夏の皮膚病(特
にあせも)に対し、塗布使用すると好ましい効果が得ら
れることも判明した。さらに本実施例で得た本剤に対し
鶏卵2個(殻の部分は除く)をミキサーで混合して含有
させ、その液剤をカット綿に浸し皮膚に生じたシミに当
てがい、その外側を気密性の高い絆創膏状の被包体で密
封あるいは密閉して使用するとシミが消失する効果も認
められた。As described above, this product may be left as it is after being applied to the affected area of athlete's foot, but if it is prevented from volatilizing from the affected area after application of this product, the effect of penetration of this product into the stratum corneum and It has been found that the bactericidal effect lasts and a favorable effect is obtained. Therefore, socks made of highly airtight rubber,
After making gloves, finger cots, and bandage-like envelopes, using them together and wearing cut cotton coated with this drug on the affected area,
A more preferable healing effect can be obtained by sealing or sealing with these encapsulants. In addition, this drug
It was also found that since it is composed of a liquid having a high acid property, it is possible to obtain a favorable effect by applying it to skin diseases (especially heat rash) in summer. Furthermore, 2 chicken eggs (excluding the shell portion) were mixed and contained in the product obtained in this example with a mixer, and the solution was dipped in cut cotton and applied to spots formed on the skin, and the outside was airtight. It was also confirmed that the spots disappeared when the product was sealed or sealed with a highly adhesive bandage.
【0012】尚、治療後の皮膚の異常等の副作用は全く
認められない。No side effects such as abnormalities of the skin after the treatment are observed.
【0013】[0013]
【発明の効果】以上のように、本発明の水虫治療剤は、
植物の抽出液を主成分としているので、無害、安全で白
癬菌の高い殺菌効果を得ることができるという優れた効
果がある。As described above, the therapeutic agent for athlete's foot of the present invention comprises:
Since it contains a plant extract as a main component, it has an excellent effect that it is harmless, safe, and has a high bactericidal effect of Trichophyton.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 35/54 7431−4C ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI technical display area A61K 35/54 7431-4C
Claims (2)
キスとを主成分としたことを特徴とする水虫治療剤。1. A remedy for athlete's foot, which comprises vinegar, garlic, and extract of Dodami Doshimi as the main components.
汁、牛乳から選ばれた少なくとも一つを含有することを
特徴とする水虫治療剤。2. A remedy for athlete's foot, which comprises at least one selected from chicken eggs, citrus juice and milk as other components.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6341171A JPH08157386A (en) | 1994-12-05 | 1994-12-05 | Athlete's foot treating agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6341171A JPH08157386A (en) | 1994-12-05 | 1994-12-05 | Athlete's foot treating agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH08157386A true JPH08157386A (en) | 1996-06-18 |
Family
ID=18343897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6341171A Pending JPH08157386A (en) | 1994-12-05 | 1994-12-05 | Athlete's foot treating agent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH08157386A (en) |
-
1994
- 1994-12-05 JP JP6341171A patent/JPH08157386A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1166575A (en) | Therapeutic dimethyl sulfoxide composition and methods of use | |
| EP3074026B1 (en) | Composition, system and method for treating skin | |
| JP2019502750A (en) | How to remove a tattoo | |
| CN114272150A (en) | Cutin stripping composition for cutin layer tissue and cutin stripping product | |
| US5858372A (en) | Herbal medication for the treatment of psoriasis | |
| RU2314093C2 (en) | Curative-cosmetic agent | |
| JPH08511283A (en) | Product for skin regeneration and treatment, method for producing the same and use thereof | |
| EP0188501A1 (en) | Process for the preparation of a pharmaceutical composition influencing the tissue metabolism and having a regenerating action | |
| KR100782577B1 (en) | Mask Pack | |
| Drury | Tea Tree Oil: A medicine kit in a bottle | |
| JPH08157386A (en) | Athlete's foot treating agent | |
| US5616619A (en) | Topical composition for burn relief and method of use | |
| RU2275898C1 (en) | Method for cosmetic rehabilitation of skin tissues in post-operating and other posttraumatic conditions (variants) | |
| JP2000290146A (en) | Solution obtained by extracting active ingredient contained in citrus unshu marc. with organic solvent using carrier oil as solvent liquid or hair growth agent and skin care oil with carrier oil containing the same | |
| RU2211024C1 (en) | Method for taking care of dry skin | |
| EP0699443A1 (en) | Elder-containing skin preparation | |
| JPH08154967A (en) | Cover material for treating dermatophytosis | |
| RU2189245C1 (en) | Cleansing cosmetic gel | |
| KR100470348B1 (en) | Rumex crispus linne contained inhibition activity against mycosis | |
| KR101040011B1 (en) | Demodex fungicide | |
| RU2345782C2 (en) | Porifera-based therapeutic compositions for skin disease treatment and prevention | |
| KR20040056081A (en) | Cosmetic composition for preventing and therapeutic for a pimple | |
| Jackson | The Ready-reference Handbook of Diseases of the Skin | |
| RU2281752C2 (en) | Liposomal concentrate for treatment and care for hair of dry type | |
| KR960015725B1 (en) | Hair Treatment Composition |